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ABSTRACT OF THE THESIS 
 
Evaluating Patient-Specific Computational Models of Dyssynchronous Heart Failure 
 
By 
 
Michael Russell Young 
Master of Science in Bioengineering 
University of California San Diego, 2018 
Professor Andrew D. McCulloch, Chair 
 
 
Cardiac resynchronization therapy (CRT) is an effective treatment for dyssynchronous 
heart failure. Most patients perform better during clinical tests of cardiac function and may 
even have their hearts reverse remodel to a more normal state. As many as 30-40% of 
patients, however, do not respond. A focus of current research is identifying which patients 
will respond to CRT, though current clinical indications for CRT are based on dyssynchrony 
and heart failure and not on validated predictors of CRT response. In this thesis, five patient-
specific computational models based on non-invasive data were developed and compared with 
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eight previous patient-specific models that were based on more detailed and invasive clinical 
information to test whether the dyssynchrony metrics from the original study were still 
predictive in the new group. Model properties such as the volume fraction of negative work 
(VFNW) and coefficient of variation of work (COVW), that had correlated with patient 
outcomes in the original cohort, did not correlate with reverse remodeling as measured by 
reduction in end-systolic volume in the new group. The sensitivity analysis showed that these 
quantities were sensitive to the parameters of ventricular filling mechanics that could not be 
included in patient-specific models based on non-invasive data. Non-invasive estimates of 
filling parameters are available, but their reliability has been questioned. We conclude that it 
is likely to be necessary to obtain invasive measurements of diastolic pressures for patient-
specific models to predict CRT outcomes. However, these measurements are available by 
cardiac catheterization, which could be justified for CRT patients.  
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Chapter 1 : Background 
1.1  Cardiac Anatomy and Physiology 
The heart is a mechanical pump that generates pressure differentials to drive blood 
flow. The right atrium and ventricle deliver deoxygenated blood to the lungs via the 
pulmonary arteries. The left atrium and ventricle receive the blood from the lungs via the 
pulmonary veins and deliver oxygenated blood to the rest of the body through the systemic 
arteries. These two circulatory systems ensure that the various tissues of the body are 
provided with enough oxygen and nutrients to perform their functions.   
The ventricles are the chambers that are responsible for generating the pressure 
differentials that cause the blood to flow through the arteries. Because the systemic blood 
vessels perfuse much more of the body, the left ventricle operates at higher pressures. The 
atria are responsible for collecting the blood from the veins and filling the ventricles. Uni-
directional blood flow is maintained by four valves: the mitral valve, the tricuspid valve, the 
aortic valve, and the pulmonary valve. The mitral and tricuspid valves are between the left 
and right atria and ventricles, respectively, and are known as the atrioventricular valves. The 
aortic and pulmonary valves are between the systemic and pulmonary arteries and the 
ventricles and are known as the semilunar valves. All of the valves are pressure driven. They 
shut when the pressure gradient would act to push the blood in the reverse direction and open 
when the gradient is pushing the blood in the forward direction. All of the valves are in a 
similar region of the heart, known as the valve plane. 
The muscular contractions in the heart are driven by electrical activation. In a healthy 
heart, the atria are activated first. The electrical impulse starts at the sinoatrial node and 
travels across the atria towards the valve plane.  There is a short delay at the atrioventricular 
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node to allow the contracting atria to fill the ventricles, and then the electrical activation 
travels through the bundle of His to the left and right bundle branches to the left and right 
ventricles, which are activated synchronously to eject the blood.  This synchronous activation 
is important for efficient contraction and blood ejection, and dyssynchronous activation can 
lead to a type of heart failure called dyssynchronous heart failure (DHF). 
 
1.2  Dyssynchronous Heart Failure 
When the conduction through the left bundle branch is lost, the electrical activation 
must travel through the muscular part of the heart, the myocardium, rather than the 
specialized conduction system. This is known as left bundle branch block (LBBB). LBBB 
results in a prolonged electrical activation and less efficient blood ejection. Of the people with 
heart failure, around half also have electrical conduction defects such as LBBB [1]. These 
electrical conduction defects can result in intraventricular dyssynchrony and/or 
interventricular dyssynchrony. Intraventricular dyssynchrony means that some parts of the 
ventricle are early activated, and some are late activated. Interventricular dyssynchrony means 
that the ventricles are activated at different times relative to each other.  
One way to assess the impact of LBBB on the heart is to look at the length of the QRS 
complex on the electrocardiogram (ECG) and the direction of the vectorcardiogram (VCG) 
[2]. These can give clinicians a picture of how extensive the block is and how dyssynchronous 
the electrical activation is. LBBB typically causes an increased QRS duration and left axis 
deviation. 
To assess the mechanical function of the dyssynchronous heart, echocardiography is 
typically used. Ejection fraction (EF) is used to determine how efficient the heart is at ejecting 
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blood. EF is normally greater than 55%; a low EF is one of the indicators that a patient is 
experiencing systolic heart failure. An increased end systolic volume (ESV) as measured by 
echocardiography is another indication that the patient has pathological remodeling leading to 
systolic dysfunction. Tissue doppler imaging (TDI) has been used to measure intraventricular 
dyssynchrony, by measuring myocardial motion in different areas [1] [3] [4]. To measure 
interventricular dyssynchrony, the difference between the beginning of the right and left 
ventricular flow velocity curves as measured by pulsed-wave (PW) Doppler has been used 
[1]. A therapy known as Cardiac Resynchronization Therapy (CRT) has been developed to 
correct the electromechanical dyssynchrony present in DHF. 
 
1.3  Cardiac Resynchronization Therapy 
1.3.1 Successes 
CRT is a method by which the ventricles are paced with pacemaker leads to 
synchronize the ventricular contractions to each other and to the atria. There are devices that 
pace from the septal wall in the right ventricle or both ventricles, and there are devices that 
monitor the electrical activity of the heart to sense ventricular fibrillation and defibrillate 
when it is necessary. Typically, patients are paced biventricularly with leads at the RV apex 
and LV coronary sinus. Any of these methods have been shown to improve patients’ quality 
of life and quantitative hemodynamic measures such as ejection fraction [5] [6] [7].  
CRT also aims to correct the aggravating complication in which a person with chronic 
heart failure also has a conduction issue that culminates in an even lower ejection fraction. 
Preliminary studies looking at the effects of biventricular CRT on hemodynamic parameters 
were started in the 1990s. These studies showed that in patients with end-stage chronic heart 
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failure, who were denied or not eligible for heart transplants, biventricular pacing increased 
the mean cardiac index by 25%, decreased the mean V wave by 26%, and decreased the 
pulmonary capillary wedge pressure in a small study of eight patients [8]. Cardiac index is a 
measure of the cardiac output relative to the size of the individual, V wave is a measure of 
mitral valve regurgitation, and pulmonary capillary wedge pressure is an indirect measure of 
atrial pressure. This study by Cazeau et al. shows that biventricular pacing can improve the 
amount of blood that is distributed to the body while decreasing mitral valve regurgitation and 
decreasing atrial pressure [8]. They also showed that during follow-up studies the 
improvements were reversed when the pace making device was turned off [8]. The V wave 
observation that biventricular pacing decreased mitral regurgitation was confirmed in one of 
the patients via echo-Doppler evaluation [8]. The authors suspect that this is due to the 
pacemaker synchronizing mechanical activity of the mitral valve along with the electrical 
activity of the heart, perhaps with the papillary muscles [8]. Interestingly, the authors also 
found that one of the patients had a normal electrical activation sequence when he was paced 
with one lead of the pacemaker, but the activation sequence became abnormal when he was 
paced biventricularly. The abnormal activation seemed to be due to an ischemic injury in his 
ventricular septum [8]. This study was the first to look at the short-term effects of 
biventricular pacing on hemodynamic parameters, giving evidence that biventricular pacing 
could have a substantial, immediate effect on how the heart pumps to relieve some of the 
burden on a failing heart.  
Evidence that suggests there is a significant improvement in certain hemodynamic 
parameters when a dyssynchronous, failing heart is paced biventricularly has been shown, but 
not that this increase in hemodynamic performance translates to improved performance in 
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clinical measures of cardiac function. Many papers, for example, the one by Auricchio et al 
demonstrate this [9]. They showed that in anaerobic and aerobic bicycle exercise, CRT leads 
to improved oxygen uptake [9]. The study optimized pacemaker placement and 
atrioventricular delay with respect to hemodynamic parameters and then looked at how pacing 
affected performance in peak exercise oxygen uptake, six-minute walk distance, quality of life 
score, and New York Heart Association (NYHA) functional class [9]. In all of these areas, 
patients improved significantly [9]. This study also investigated whether these clinical 
measures were significantly affected by the use of a single lead or biventricular lead. They 
found that optimal placement of a single lead (usually in the LV) could lead to similar 
increases in quality of life as biventricular leads [9].  
Increases in hemodynamic function and increases in quality of life are important 
measures of how CRT can help patients, but another critical measure of how well this therapy 
works is how effective CRT is at keeping patients alive and out of the hospital. If CRT 
increases quality of life but increases the likelihood that the patients will die suddenly of heart 
related issues, it is not a very good method for treating chronic heart failure. However, a large 
scale randomized controlled trial suggests that CRT also decreases the likelihood that a 
patient will die and the likelihood that a patient will be hospitalized for heart or cardiovascular 
related events. The COMPANION study examined 1520 patients with advanced heart failure 
and long QRS interval [7]. The patients were NYHA class III or IV and had a QRS interval 
longer than 120 ms [7]. All patients received optimal pharmacological therapy such as 
diuretics, angiotensin converting enzyme inhibitors, and beta blockers, and were assigned to 
either a control group or a treatment group [7]. The treatment groups were either a pacemaker 
or a pacemaker-defibrillator, and the primary end point for the study was time to death from 
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any cause or hospitalization from any cause [7]. The COMPANION study found that both the 
pacemaker and the pacemaker-defibrillator groups experienced a decreased risk of 
hospitalization or death from any cause [7]. Also, the risk of hospitalization or death from 
heart failure was reduced by 34 and 40 percent for the pacemaker and pacemaker-defibrillator 
groups, respectively [7].  
This COMPANION study is consistent with a meta-analysis of four randomized 
controlled trials of CRT. In a pooled analysis from the four trials, the authors found that death 
from progressive heart failure was reduced by 51 percent for patients who received CRT 
relative to controls [10]. The meta-analysis also found that CRT reduced hospitalization due 
to heart failure by 29 percent [10]. While the meta-analysis did not find a statistically 
significant difference in all-cause mortality, it did find a trend towards the reduction of all-
cause mortality by CRT [10]. These analyses show that CRT improves patient outcomes with 
respect to death and hospitalization from heart failure while also improving short term 
hemodynamic function and patient quality of life. 
 
1.3.2 Nonresponders 
While CRT has a positive effect on outcomes for most patients, around 40 percent of 
people do not respond to CRT with reverse remodeling, and determining whether a patient 
responds is difficult [11]. A proposed predictor of the effectiveness of CRT is left ventricle 
dyssynchrony as measured with TDI. Defining a non-responder as someone who did not 
improve New York Heart Association class and did not see a 25 percent increase in the six-
minute walk distance after pacemaker implantation, one can retroactively analyze the 
different factors that affected the outcome and determine what correlated best with the 
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response of patient. In one study, the dyssynchrony of the left ventricle showed the biggest 
difference between responders and non-responders, with responders having an intraventricular 
dyssynchrony of 87 ± 49 ms and nonresponders having an intraventricular dyssynchrony of 
35 ± 20 ms [4]. Receiver-operating characteristic curve analysis showed that the optimal 
threshold led to a specificity and sensitivity of 80 percent at a threshold of 65 ms of left 
ventricle dyssynchrony [4]. These data also suggest that patients who receive a pacemaker 
with left ventricle dyssynchrony less than the threshold have an increased likelihood of 
adverse events such as cardiac death and hospitalizations for heart failure [4].  
Another proposed method for identifying candidates for CRT is to measure the size of 
scar that a patient has due to myocardial infarction using delayed enhancement magnetic 
resonance imaging. Data suggest that patients with larger scar areas are more likely to be non-
responders than those without, even if their left ventricle dyssynchrony is not significantly 
different [12]. In a relatively small study of 23 patients, a scar size threshold of 15 percent of 
the myocardium predicted with a sensitivity and specificity of 85 and 90 percent, respectively, 
whether a patient would respond to CRT [12]. A septal scar less than 40 percent of the septum 
had a sensitivity and specificity of 100 percent, and percent total scar correlated linearly with 
the response criteria [12].  
More recently, a large-scale trial has suggested that of the many different ways to 
measure left ventricle dyssynchrony, none of them can be used to improve selection criteria 
for CRT. The PROSPECT trial was a large-scale trial with 53 centers in Europe, Hong Kong, 
and the United States that enrolled 498 patients with New York Heart Association class III or 
IV, left ventricular ejection fraction less than 35 percent, a QRS interval of greater than 130 
ms, and optimal pharmacological treatment, and evaluated twelve echocardiographic 
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parameters of dyssynchrony [13]. The multi-center approach of a trial like the PROSPECT 
trial would ensure that any predictor of CRT is reproducible in many different centers and 
therefore a good predictor in general for recommending CRT. The PROSPECT trial was not 
able to recommend that any of the echocardiographic measures of dyssynchrony be used to 
predict outcomes of CRT [13]. 
 
1.3.3 Hyper-responders 
While much time and energy has been spent investigating the subgroup of CRT 
patients classified as non-responders, a subgroup of patients called “hyper-responders” have 
been given much less attention. One reason this may be is that they make an almost complete 
return to normal cardiac function after CRT and therefore do not require any additional 
solutions. However, if this group could be well understood, then perhaps the mechanisms by 
which CRT does not work could be understood. In one study, the “hyper-responders” went 
from an ejection fraction of 25 ± 8 percent to an ejection fraction of 60 ± 6.5 percent after 
CRT [14].  The return to completely normal ejection fraction after CRT suggests that the 
dyssynchrony and the left bundle branch block were the primary causes of the chronic heart 
failure [14]. Interestingly, all the hyper-responders were from the group of patients with non-
ischemic chronic heart failure [14]. This suggests that if researchers could accurately 
determine what effects an ischemic injury has on the conduction and contraction of the 
myocardium, then the outcomes of CRT could be accurately predicted.  
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1.4  Dyssynchrony Metrics 
Many methods have been developed to distinguish between non-responders, 
responders, and hyper-responders. These techniques range from purely electrophysiological to 
mechanical in nature. Though all have them have demonstrated some ability to differentiate 
between the different groups, none have them have been proven to work consistently enough 
to be used to guide indications of CRT. This thesis will use some of these metrics calculated 
from finite elements simulations to predict response to CRT. 
 
1.4.1 QRS Area 
In one study of 57 patients, QRS area identified echocardiographic responders with a 
10.2 odds ratio. This objective measure of patient electrophysiology performed at least as well 
as the most refined definition of LBBB [15]. QRS area is determined from the VCG and is 
defined as (QRSx2 + QRSy2 + QRSz2)1/2 where QRSx, QRSy, and QRSz are the time-
integrated VCG in the x plane, y plane, and z plane, respectively [15]. The areas under the 
receiver operator characteristic curves were analyzed for several potential ECG and VCG 
metrics, and QRS area was had the largest area under the curve (AUC) of all of the metrics 
that were tested, beating QRS amplitude and QRS duration, as well as LBBB classifications 
[15]. QRS area may be clinically relevant because all patients will receive an ECG, so any 
metrics that could be directly derived from it could be used immediately by any hospital.  
 
1.4.2 Circumferential Uniformity Ratio Estimate  
The circumferential uniformity ratio estimate (CURE) is a metric derived from Fourier 
analysis of magnetic resonance- myocardial tagging (MR-MT) data [16]. It determines the 
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ratio of first- to zero-order power. A CURE of 0 represents pure dyssynchrony and a CURE of 
1 represents complete synchrony. In control subjects, CURE indicated synchronous 
contraction even in patients where TDI indicated dyssynchrony [16]. CURE predicted 
improved NYHA function class with 90% accuracy [16]. CURE has since been used in a 
somewhat larger study of 75 patients, and it appears to be an accurate method for determining 
LV dyssynchrony and possibly differentiating between CRT responders and nonresponders, 
when the scar and delay of circumferential contraction at LV lead are taken into consideration 
using multivariate logistic modeling [17].  
 
1.4.3 Internal Stretch Fraction 
The internal stretch fraction (ISF) is a metric defined as the ratio of stretch to 
shortening during ejection [18]. This metric determines the amount of mechanical 
discoordination rather than mechanical dyssynchrony, because it does not look at the relative 
times that the stretches occur. Magnetic resonance with myocardial tagging (MR-MT) was 
used to calculate circumferential strain in the LV midwall, and the ISF was calculated by 
separating the strains that occur during ejection into stretching and shortening and finding the 
ratio between them [18]. In a study of 19 patients, the ISF was shown to be significantly 
higher in responders versus the nonresponders [18]. A difference between CURE and ISF is 
that the CURE assumes a sinusoidal spatial variation of strains, while the ISF does not.  
 
1.4.4 Coefficient of Variation of Regional Work 
The coefficient of variation of regional work (COVW) is a computational model-
derived metric that represents the amount of heterogeneity in work throughout the 
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myocardium. The COVW is calculated from finite elements simulations by calculating the 
work from the stress and strain at each gauss point and dividing the standard deviation of the 
work by the mean of the work. Locations that are early activated tend to have low or negative 
work, because the strain and stress do not occur synchronously. When some areas are 
performing low or negative work, and others are performing high work, the COVW will 
increase. One paper showed that the COVW was sensitive to a LBBB activation pattern and 
may be a useful metric for determining dyssynchrony [19]. 
 
1.4.5 Volume Fraction of Negative Work 
The volume fraction of negative work (VFNW) is another model-derived metric that 
represents the dyssynchrony of a contracting heart model. Negative work from this 
perspective means that the myofibers are lengthening during contraction instead of 
shortening. VFNW is calculated from finite elements simulations by calculating the work at 
each gauss point, then finding the volume associated with the gauss points that performed 
negative work and dividing by the total volume represented by the element or elements of 
interest. The VFNW may be calculated in certain areas of interest, such as the septum 
(VFSTNW) or the LV (VFLVNW).  
 
1.5  Finite Element Models for Cardiac Electromechanical Simulations 
Methods for developing finite element models for cardiac electromechanical 
simulations have been around for quite some time [20] [21] [22]. And in the last couple 
decades, finite element models with physiological circulatory models fully coupled to them 
been developed and made patient-specific [23] [24] [25] [26] [27]. The essential components 
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for these electro mechanical models are: cardiac geometry, an activation pattern, a 
constitutive model, an active model, and a circulatory model. 
 
1.5.1 Cardiac Geometry 
Before patient-specific geometries were readily available via computed tomography 
(CT) and magnetic resonance (MR), cardiac models were gross approximations that modeled 
the heart as a cylinder or a partial prolate spheroid [20] [21]. These models were able to 
provide general information about stresses and strains that were widely applicable, because 
the modeling error was greater than the patient-to-patient variability. Now, however, there are 
methods of making cardiac geometries that capture this variability and make patient-specific 
observations and predictions [26] [27].   
 
1.5.1 Activation Pattern 
Without a plausible activation pattern for these models, they could not capture the 
dyssynchrony of the patients. One method to create activation maps is to use computational 
models of electrophysiology with the patient-specific geometries to optimize the activation 
pattern to the clinically measured VCG [28].  
 
1.5.2 Constitutive Models 
The myocardium is a highly non-linear and anisotropic material, so the choice of 
constitutive model for the finite element simulation will be an important determining factor of 
the validity of the model. The myocardium is made of fibers that vary in direction based on 
their location. The fibers are arranged in sheets with other fibers that are in the same direction. 
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Because the myocardium is made of fibers and sheets, the mechanical properties are different 
in these directions. Models that consider the fiber direction but treat the sheet direction the 
same as the third direction, the sheet normal direction, are known as transversely isotropic 
constitutive models. Models that treat all three of the directions differently are known as 
orthotropic constitutive models.  
Transversely isotropic models that have been proposed are typically simpler than the 
orthotropic counterparts, as they treat two directions the same. The first anisotropic model that 
considered the fiber structure was a sum of two exponential terms that had four material 
parameters [29]. Another empirical, transversely isotropic model is a five-parameter 
polynomial that had different values across the ventricular wall [30]. These models were 
developed when the myocardium was thought to be transversely isotropic, but the anisotropy 
in the cross-fiber directions has since been shown [31].   
To capture the orthotropic nature of the myocardium, Fung-type exponential models 
with 7 or 12 material parameters were first developed [32] [33]. More recently, an orthotropic, 
convex constitutive model with parameters that are intuitively related to the underlying 
histology has been proposed [34]. 
 
1.5.3 Active Tension Models 
Active tension models are needed to simulate the contractile forces inside the 
myocardium. The aforementioned fibers of the constitutive model are not passive materials 
but are made up of cardiomyocytes. Located inside of the cardiomyocytes are the contractile 
elements, known as sarcomeres. The proteins that make up sarcomeres slide along each other 
when activated by calcium transients. Some mathematical models of the myocardium model 
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the contraction of sarcomeres as an applied strain [35]. Physiologically, this is not accurate 
because the force increases in cardiac tissue whether the contraction is isometric, concentric, 
or eccentric. For this reason, models that use an active stress component added to the passive 
stress are more popular [36]. 
 
1.5.4 Circulatory Model 
 The best known and perhaps simplest circulatory models is the Windkessel model. It 
contains two components, an aortic compliance and a systemic resistance. The two-element 
Windkessel model does not provide accurate pressure waveforms with aortic flow as the 
input, so Windkessel models with three elements were developed [37]. While these models 
lead to accurate waveforms, the parameters did not closely correspond to physiological 
measurements. A fourth element was added to correct for this [38]. More parameters, for 
things like the baroreflex, blood volume regulation, and blood gas handling can be 
incorporated for a more integrated lumped parameter model, but the problem quickly becomes 
that there are too many parameters to fit each of them individually, especially for a patient-
specific model. One solution to this problem uses physiological rules to find reasonable 
parameters for these processes without having to measure them directly, allowing patient-
specific lumped parameter models with realistic physiology [39]. 
 
1.6  Specific Aims 
CRT has proven to be an effective treatment for dyssynchronous heart failure in most 
patients with a long QRS duration, LBBB activation pattern, and an elevated ESV. CRT can 
improve quality of life, short-term heart function, and even lead to reverse modeling of the 
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ventricle to a more normal ESV. However, around 40% of patients that receive CRT do not 
respond [11]. Many metrics have been developed to try and separate the responders and non-
responders so that only responders will receive CRT. None have proven to reproducibly 
separate patients in large, diverse cohorts. More recently, patient-specific electromechanical 
models have been used to model the diseased state, so the outcomes of CRT can be predicted. 
These models have not been validated thoroughly, and it is unclear how useful these models 
will be clinically, as they require invasive measurements.  
To solve this problem, patient-specific models were developed from non-invasive 
clinical measurements. Average parameters from a previous cohort of patients were used 
wherever clinical measurements were unavailable. Metrics from the models were compared to 
models that contained invasive measurements. The sensitivity of the metrics to the parameters 
that went into the model was analyzed to determine what information is important to measure 
clinically. Knowing what the metrics are sensitive to will help us decide what clinical 
information should be included in these models and how closely the models need to match the 
clinical data. 
Dyssynchrony metrics (ISF, CURE, COVW, VFNW) and their correlations with 
reverse remodeling as measured by change in ESV are compared between the two groups. 
The relative range of the metrics and predictive value of them are examined to determine if 
the models provide consistent results to their more patient-specific counterparts. 
Circulatory model, active tension model, activation pattern, and geometry patient-
specific parameters were each replaced with the average of the parameters from the patient 
group, to determine how important these parameters are to the aforementioned metrics.  
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Chapter 2 : Methods 
 Five electromechanical computational models were developed that captured patient-
specific geometry, hemodynamics, and electrical activation. These models were compared 
with models that also included patient-specific mechanics and more hemodynamic 
information obtained via invasive measurements. The latter models were previously made 
[40]. The process by which the former were made is explained in this chapter. Meshes are 
generated from CT data, then electrical activation information is added, and hemodynamic 
parameters are estimated from echo data. Finally, heart beats are simulated until a steady state 
is reached and several metrics are calculated. This process is very similar to previous 
modeling work from the Cardiac Mechanics Research Group [26] [27].  
 
2.1  Patient Data Collection 
De-identified CT images and echocardiographic data were obtained from University 
of California, San Diego Healthcare System. Three male and two female patients with dilated 
cardiomyopathy (DCM), LBBB, and NYHA class II-III heart failure had all the necessary 
data at the necessary time points to be included in this study. Patient characteristics are 
summarized in Table 2.1.  
Table 2.1: Summary of echocardiographic data retrieved prior 
to CRT device implant 
Age 70 ± 7  
EF 29 ± 5 
LVEDV 167 ± 49 
QRS Duration 156 ± 13 
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2.2  Mesh Generation 
Patient CT scan data was segmented and exported via OsiriX. Separate segmentations 
were performed for the blood volume and myocardium. From these two segmentations, the 
epicardial and endocardial surfaces can be obtained. The segmentation data was imported into 
Blender, where it was smoothed and split into RV endocardial, LV endocardial, and epicardial 
surfaces. Subdivided icospheres were shrink-wrapped onto the smoothed surfaces to provide 
further smoothing. A 209-node template was fit to the shrink-wrapped objects such that the 
error from the segmentation and distortion of the faces were minimal.  
The nodes were converted into prolate spheroidal coordinates, which are convenient 
for approximating the shape of the heart, by an algorithm that numerically estimates the value 
of µ and then calculates the values of ν and φ given the focal length, α. First, a guess of µ is 
initiated, then the y coordinate that would result from that µ, yg, is calculated using Equation 
1. Using the difference between, y and yg, the µ is scaled until yg is within a threshold of y. 
Then, the other values are calculated using Equation 2 and Equation 3. 
yg = α sinh(μ) sin (arccos
𝑥
𝛼 cosh(𝜇)
) cos arcsin
𝑧
𝛼 sinh(𝜇) sin (arccos
𝑥
𝛼 cosh(𝜇)
)
(1)
 
ν = Re (arccos
𝑥
𝛼 cosh 𝜇
) (2) 
θ = Re (arcsin
𝑧
𝛼 sinh 𝜇 sin 𝜈
) (3) 
The prolate spheroidal nodes were imported into Continuity, where the nodal 
coordinates were transformed into a tricubic Hermite finite elements mesh in cartesian 
coordinates. An example of what the stages of this process look like from segmentation to 
finite element mesh is given in Figure 2.1. 
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2.3  Fiber Fitting 
The constitutive models discussed in 1.5.2 all have the stresses and strains with respect 
to the fibers of the tissue. In the current state, however, the models do not contain information 
about the direction of the fibers. To add fiber and sheet information, large deformation 
diffeomorphic mapping is used to map diffusion-tensor MRI data obtained from an isolated, 
fixed donor heart onto the finite element mesh. Fiber directions are shown in Figure 2.2. 
 
 
 
 
Figure 2.1: (A) Segmentation of CT imaging data. (B) Smoothed surfaces representing the 
LV endocardium (red) the RV endocardium (blue) and the epicardium (yellow). (C) 209-
node template fit to the smoothed surfaces. (D) Finite element mesh after cubic splines were 
created in prolate spheroidal coordinates. 
A B 
C D 
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2.4  Electrical Activation Maps 
The electrical activation is what separates dyssynchronous heart failure from other 
types of heart failure. To ensure the models represented a dyssynchronous heart, patient-
specific electrical activation maps were developed using the same methodology as the 
previously published models [28]. The finite element model developed previously was refined 
and exported back to Blender. A 280-node template was manually fit to the mesh-derived 
endo- and epicardial surfaces. HexBlender was used to calculate cubic derivatives and export 
the mesh back to Continuity, where the conductivity and stimulus location was adjusted to 
find the optimal combination to match the patient data. More specifically, the ECG was 
transformed to a VCG using the Kors method [41]. VCGs calculated from the finite element 
model were rotated into the same reference frame. The angular deviation between the Kors 
VCG was calculated and the simulation that had the least deviation was chosen. A mesh used 
in electrophysiological simulations and an example activation map are shown in Figure 2.3. 
 
Figure 2.2: (A) Close up on an element, showing the transmural variation in fiber angle. (B) 
Showing spatial variation of fiber angle on the LV free wall. 
 
A B 
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Figure 2.3: (A) An example electrophysiology finite elements mesh. This mesh would be 
subdivided for simulations. (B) An example of an LBBB activation map. Red is early 
activated, and blue is late activated. 
 
2.5  Constitutive Model  
The constitutive model used in these models is the Holzapfel and Ogden orthotropic 
model [34]. The model can be expressed in terms of the strain energy function shown in 
Equation 4, with the last term added to incorporate the slight compressibility of the 
myocardium. The invariant I1 and quasi-invariants I4i and I8fs are defined in Equations 5, 6, 
and 7, respectively, where C is the right Cauchy-Green tensor, and i0 is the unit vector for the 
fiber, sheet, or sheet-normal direction.  
Ψ =
a
2b
eb(I1−3) + ∑
ai
2bi
[ebi(I4i−1)
2
− 1]
i=f,s
+
afs
2bfs
[ebfsI8fs
2
− 1] +
𝜅
2
(𝑑𝑒𝑡(𝑭) − 1)𝑙𝑛(𝑑𝑒𝑡(𝑭))(4) 
𝐼1 = 𝑡𝑟(𝐂) (𝟓) 
𝑰𝟒𝒊 = 𝒊𝟎 ⋅ (𝐂𝒊𝟎) for 𝒊 = 𝒇, 𝒔, 𝒏 (𝟔) 
 
The material parameters: a, b, af, bf, as, bs, afs, and bfs are positive material constants, 
where all “a” parameters have units of stress, and “b” parameters are dimensionless. The 
𝐼8𝑓𝑠 = 𝒇𝟎 ⋅ (𝑪𝒔𝟎) (7) 
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subscripts: f, s, and n denote the fiber direction, sheet direction, and sheet normal direction, 
respectively. κ is the bulk modulus and F is the deformation gradient tensor. Values for each 
of these parameters were the average of the previous cohort [40]. 
 
2.6  Unloading Algorithm 
With the patient-specific cardiac geometry, fiber orientation, and constitutive model in 
place, the unloading algorithm can be performed. The aim of the unloading algorithm is to 
obtain a plausible unloaded (zero-pressure) geometry for the heart. This is important for 
obtaining accurate values for stress during the full beat simulation. During the cardiac cycle, 
the heart is never at zero stress, and the unloaded state can only be truly found in an excised 
heart.  
The algorithm works by inflating the end diastolic geometry to an end diastolic 
pressure (EDP). We did not know the patients’ EDP, so we used the average of the previous 
cohort. The algorithm then calculates the deformation between the inflated geometry and the 
end diastolic geometry. The inverse of this deformation is applied to the starting geometry in 
a deflation step. The new deflated geometry is then inflated again. The inflation and deflation 
steps are repeated until the inflated geometry at EDP is sufficiently close to the measured end 
diastolic geometry. This process is the same as in the previous patients [26] [27] [40].  
 
2.7  Active model 
The active model is a Hill-type model, that uses two state variables: a contractile 
activation variable similar to calcium concentration in the sarcomere, and the length of the 
sarcomere. The sarcomere is modeled as a strain rate dependent element in parallel with a 
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contractile element and a strain dependent element in series. The rise and decay constants of 
the contractile element and a stress scaling factor for the peak tension development were 
adjusted to match the pressure tracings of the previous cohort. The average rise and decay 
constants were used in the new models, but the stress scaling factor was adjusted to match the 
clinical peak pressure data [36].  
  
2.8  Circulation Model 
The CircAdapt model was used, because physiological rules are used to find 
parameters that are not readily measurable clinically. Certain parameters, like the valve 
diameters, cardiac output, and mean arterial pressure, that are obtained by echocardiography 
were input into the model, and the model was allowed to adapt to give parameters that are 
consistent with the physiological rules that CircAdapt uses [39].  
CircAdapt divides the circulatory system into modules: chambers, tubes, valves, and 
resistances. The atria and ventricles are modeled as chambers, where pressure depends on 
volume and sarcomere length. The major arteries and veins are modeled as tubes, where 
pressure only depends on volume. The capillary beds are modeled as resistances where the 
flow rate is a function of the pressure drop across them. There are six valve modules in the 
model, four for the actual valves in the heart, and two that represent the inertia of the blood at 
the entrance to the atria.  The valves are flow ducts where the cross-sectional area depends on 
flow and transvalvular pressure [20].  
Physiological rules for the tubes aim to maintain a consistent shear rate on the 
endothelium while keeping the wall stress under some maximum by changing the wall 
thickness and area. Chamber geometry is adjusted by changing the contractility and scaling 
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the wall volume accordingly. The pulmonary peripheral resistance is adapted to match the 
pressure drop across the lungs [20].  
The CircAdapt model results in a set of ordinary differential equations (ODEs) That, 
when solved simultaneously, give accurate pressure wave forms and flows. The CircAdapt 
was first implemented in MATLAB, where many iterations of the model could be run in a 
relatively short time. The input parameters were adjusted such that the post-adaptation 
pressure-volume loops gave accurate peak pressure, EDP, and EF. The steady-state 
parameters for this model were then input into Continuity for the finite element full beat 
simulations’ boundary conditions. 
 
2.9  Full Beat Finite Elements Simulations 
The end diastolic geometry, fiber information, activation map, constitutive model, 
unloaded geometry, active model, and circulation model were all combined in Continuity and 
run until the beats reached steady state. The finite elements simulation was solved to 
minimize cavity volume error using Newtonian iterations [23]. The EF and peak pressure 
were optimized to the measured values for our patients by adjusting the circulation model. 
The input parameters of the MATLAB CircAdapt model were scaled to adjust for errors 
between the heart model in CircAdapt and the finite element model. 
 
2.10  Dyssynchrony Metrics 
QRS area was calculated using the method outlined in section 1.4.1, from clinical 
ECG’s for each patient. The CURE, ISF, VFSTNW, and VFLVNW were calculated from a 
script in MATLAB. Each was calculated according to the methods discussed in section 1.4.  
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Chapter 3 : Results 
3.1  Model Comparison 
The methods described above were used to generate five patient-specific models with 
mechanical properties and EDP that were the average of models where those data were 
known. The five patient-specific models developed for this thesis are called the “new models” 
or “new cohort,” and the set of models from which the parameters were averaged is called the 
“previous models” or “previous cohort.” The previous cohort followed similar methods but 
were developed with patient-specific mechanics that matched a pressure tracing from a 
ventricular catheter. Throughout the results section, these sets of models are compared to 
provide insight into what is important for calculating accurate patient-specific metrics of 
dyssynchrony. 
 
3.1.1 Comparison with Patient Data 
Though the model cohorts were built with different information, it will be useful to 
look at what clinical data was matched and how closely it was matched to discuss the validity 
of the models. The finite elements models were built from CT imaging and most of the rest of 
the patient data were obtained via echocardiography. To determine how consistent the 
echocardiographic and CT anatomies were, geometrical measurements similar to the ones 
obtained via echocardiography were gathered for the CT-derived meshes. These 
measurements include: interventricular septal thickness at diastole (IVSd), left ventricular 
internal dimension at diastole (LVIDd), and left ventricular posterior wall at diastole 
(LVPWd). Similarly, the QRS measured from the ECG is compared to that of the models. 
These data are shown in Figure 3.1. 
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Figure 3.1: Comparing the two cohorts and the fitting of the data. The red is the new cohort 
and the black is the previous cohort. The lines connecting points from echo to model show 
the pairing of the data. The dots on the vertical lines are the mean, and the error bars are the 
standard deviation. (A) Comparison of the IVSd from clinical echo measurements and from 
the CT-derived model. (B) Comparison of LVIDd from echo and the CT-derived model. (C) 
LVPWd from echo and CT-derived model. (D) The QRS durations from the ECG and the 
model. Notice that the new cohort has, on average, longer QRS duration. 
 
 
The activation maps were optimized to give a VCG that was as close as possible to the 
VCG constructed from the patient ECGs. The old cohort had a much more consistent 
activation pattern, with all of the patients’ activation starting apically and close to the septum. 
The new cohort had activation patterns that ranged from apical and septal to more basal and 
towards the RV free wall. The activation maps are shown in Figure 3.2.  
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Figure 3.2: A view of the right ventricle of the model geometries. The outside is basal, and 
the middle is apical. (A) The earliest activated nodes for the previous cohort. There are fewer 
nodes than patients, because the same node was earliest activated for more than one patient. 
(B) The earliest activated nodes for the new cohort. Notice the larger variation in this cohort, 
with relatively more free-wall activation. 
 
 
In the previous cohort, catheter pressures from the ventricles throughout cardiac cycle 
were available. Because of this, the mechanical properties were adjusted to match the -
maximum and minimum pressure rates (dP/dt) in the ventricles and EDP. The new patients 
used the average mechanical properties and average EDP. Because of this, the new cohort had 
a much more consistent dP/dt. These data are summarized in Figure 3.3. 
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Figure 3.3: Comparison of dP/dt max from the previous cohort (black) and the new cohort 
(red). Notice the smaller range for the new cohort, because this was not fit to patient data. 
Instead, it correlates with the peak pressure. 
 
Other hemodynamic data that were matched to clinical data are the EF, peak cuff 
pressure, and degree of mitral regurgitation. The mitral regurgitation was graded as trace, 
mild, moderate, and severe and was modeled by varying the lumen area of the mitral valve 
when its closed from 0.5% to 5% of its open area. The EF and peak pressure data are 
summarized in Figure 3.4. 
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Figure 3.4: (A) The comparison of EF. Because the new cohort (red) was fit to the patient 
EF, it is much closer to the measured values. (B) The peak pressure was also fit in the new 
cohort instead of dP/dt max, so the models match the cuff peak pressure better. 
 
3.1.2 Comparison of Metrics 
The purpose for building these models is to determine which patients will respond to 
CRT and which patients will not. Typically, metrics of dyssynchrony are used, because a 
highly dyssynchronous heart theoretically has more opportunity to be made synchronous and 
therefore improve due to CRT. Many metrics have been developed in the literature, but the 
ones that will be focused on are VFLVNW, VFSTNW, COVW, CURE, and ISF. These 
metrics are discussed in detail in Chapter 1. Reverse remodeling as measured by a reduction 
in ESV is a common clinical endpoint for CRT response studies because reverse remodeling 
indicates that the pathologically dilated heart is remodeling to a more normal heart. The 
metrics will be used to predict reverse remodeling. 
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Figure 3.5: The left column shows the mean and variation of the metrics themselves. The 
right column shows the correlation with reverse remodeling. (A) New cohort (red) has less 
variation and is in general less dyssynchronous. (B) The VFLVNW vs. ESV reduction. A 
higher ESV reduction indicates a bigger response to CRT. The lines are linear regressions.  
Previously, the data had a strong correlation (r2 = .9) that could separate responders from 
nonresponders. The correlation does not exist in the new cohort (r2 = .03). (C) There is less 
variation and they are less dyssynchronous. (D) The modest correlation that existed in the 
previous cohort (r2 = .5) is not there (r2 = .2). (E) Again, the new models are more consistent 
and less dyssynchronous. (F) The correlation (r2 = .6) is not existent in the new cohort (r2 = 
.08). 
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3.2  Sensitivity Analysis 
The previous models were built using the catheter pressures, such that the ventricular 
pressures throughout the cardiac cycle were known. The new models do not reproduce the 
same results although some variables, such as COVW and VFLVNW, showed similar trends. 
It is possible that the new models are accurately representing patient physiology, and the 
metrics are not useful for determining who will respond to CRT. It will be useful to determine 
what model parameters these metrics are sensitive to, so discussion of the validity of the 
models is well informed. For the sensitivity analysis, the previous models were used, so that 
the effect of average mechanical parameters could be investigated 
 
3.2.1 Effects of Using Average Input Parameters 
Several aspects of the previous models were made patient-specific, namely: the 
geometry, the activation pattern, the constitutive model, the dynamic model, and the 
circulation model. To see which of these model parameters affected the metrics, each one of 
them was changed to the average of the cohort while the others were left patient-specific and 
the metrics were recalculated. The normalized root mean squared deviation (nRMSD) from 
the fully patient-specific model to the models with one feature averaged was calculated, and 
the relationship between ESV reduction was investigated. The results are shown in Figure 3.6. 
The metrics were most sensitive to the average circulation model, and least sensitive to the 
average mechanics model.  
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Figure 3.6: (A) Heatmap showing the nRMSD from the fully patient-specific model to the 
averaged parameter listed on the left. CA is the circulation model, ME is mechanical 
properties, CT is the geometry, and AT is the activation pattern. The bottom labels designate 
for which metric the nRMSD was calculated. Beige indicates a large change when the 
parameter was averaged, and purple indicates a small change. The average circulation and 
geometry had large effects on these metrics. (B) Heatmap showing the r2 value between the 
metric at the bottom and the ESV reduction. The circulation model again had a large impact 
on all of the metrics except ISF, which did not originally show a correlation. The impact of 
averaging the geometry seems to be to increase these correlations, except in the VFLVNW. 
  
3.2.2 Identification of Important Global Features 
Identifying important clinical data to use to parameterize the models to give metrics 
that may be representative of patient CRT response can inform the collection of patient data 
for future studies. Features that are important for getting accurate work metrics will likely 
change when the metrics change and remain unchanged when the metrics do not change. 
Global, potentially clinically measurable features were calculated from the models. The 
features from patient-specific models were correlated with the same features from the models 
with average circulatory parameters, which changed the metrics the most. Also, they were 
correlated with the features from the models with average mechanical properties, which had 
the least effect on the metrics. The features that had little correlation in the average circulation 
model case and a strong correlation in the average mechanics case behaved similarly to the 
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metrics and are therefore likely important factors to match to clinical data, when possible. 
These features are RV and LV EDP, RV EDV, and LV maximum filling rate (dV/dt max). 
These data are summarized in Figure 3.7. 
 
Figure 3.7: (A) The LVEDP from the fully patient-specific models plotted against the 
LVEDP from both the average circulation models and the average mechanics models. The 
line of best fit has the r2 value and slope indicated in the heatmaps C and D. An r2 value and 
slope of 1 indicates no change in the parameters. This example shows that the circulation 
model has a large effect and the mechanics has very little effect. (B) The ejection rate, dV/dt 
min is affected by mechanics more than the circulation model. (C) The r2 values for the 
trendlines for each model are shown as a heatmap. (D) The slope of the trendline for each 
model. 
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The circulation model is crucial for calculating accurate dyssynchrony metrics. To 
determine which circulation parameters are related to the metrics, the residuals were 
correlated. The difference between each patient-specific parameter and the average of the 
parameter was plotted against the difference between the metrics under the fully patient-
specific and average circulation model conditions. When the correlation is strong, it means 
that a change in that parameter is related to a change in the metric, and the more the parameter 
is changed, the more the metric is changed. This does not prove causation. The four 
parameters that correlated most strongly with each metric and how strongly they correlated 
are shown in Table 3.1. Most of them are related to ventricular preload and filling, and not as 
much the ventricular afterload. 
 
 Table 3.1: Results of correlating the residuals for the circulatory model. The four parameters 
that correlated best are shown. Notice how most have to do with ventricular filling via vein 
pressure or the atria. 
VFLVNW VFSTNW COVW ISF CURE 
Parameter r2 Parameter r2 Parameter r2 Parameter r2 Parameter r2 
Left atrial 
reference 
midwall 
area 
0.79 
Pulmonary 
veins 
reference 
pressure 
0.66 
Pulmonary 
veins 
reference 
pressure 
0.74 
Left atrial 
reference 
midwall area 
0.87 
Left atrial 
reference 
midwall area 
0.68 
Right atrial 
reference 
midwall 
area 
0.77 
Left atrial 
reference 
midwall 
area 
0.66 
Average LV 
short axis 
area 
0.69 
Right atrial 
reference 
midwall area 
0.85 
Right atrial 
reference 
midwall area 
0.67 
Pulmonary 
veins 
reference 
pressure 
0.65 
Average LV 
short axis 
area 
0.64 
Left atrial 
reference 
midwall area 
0.62 
Tricuspid 
valve lumen 
area when 
closed 
0.78 
Aorta 
unloaded 
lumen area 
0.59 
Average LV 
short axis 
area 
0.64 
Right atrial 
reference 
midwall 
area 
0.63 
Pulmonary 
artery 
reference 
pressure 
0.62 
Average LV 
short axis 
area 
0.51 
Tricuspid 
valve lumen 
area when 
closed 
0.58 
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Chapter 4 : Discussion 
4.1  Simulation Findings 
In this thesis, five models with patient-specific geometries, activation patterns, EF, and 
peak pressure were developed. These models were compared to eight fully patient-specific 
models that also included patient-specific EDP, dP/dt, and mechanical properties. The new 
models were used to attempt to reproduce findings from the previous models, specifically that 
VFSTNW and VFLVNW are good metrics of dyssynchrony to predict reverse remodeling 
due to CRT. Also, a sensitivity analysis was performed to determine which inputs to the 
model are important for accurate dyssynchrony metrics. Patient-specific electromechanical 
models that do not contain patient-specific catheter pressure tracings are not able to reproduce 
the same predictive dyssynchrony indices as previous models. Sensitivity analysis suggests 
that while EDP is required, the full pressure tracing is not necessary to make accurate CRT 
predictive models. 
The new models did not predict CRT response as well as the previous models, though 
they did display similar trends. The discrepancy may be because the two cohorts were 
different. The current group had longer QRS duration, because the guidelines for CRT were 
changed between the two cohorts. The activation patterns for these models were different in 
that they spanned a larger area of the RV and that they were on average more towards the RV 
free wall. Also, the previous models were matched to ventricular pressure tracings, while the 
new cohort only knew the peak pressure from a cuff blood pressure measurement. The dP/dt 
max has previously been identified as a potential predictor of response, though the sensitivity 
analysis suggests that it is not an important parameter for the dyssynchrony metrics [42]. The 
new models were consistently less heterogeneous by all the metrics that were calculated, and 
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the metrics spanned a smaller range. Either these patients had metrics that accurately 
represented their physiology and the metrics are not that useful for determining response to 
CRT, or the models did not capture the dyssynchrony present in the patients.  
The sensitivity analysis suggests that the ventricular filling and EDP are important 
aspects to capture to ensure that the metrics that are calculated represent patient physiology. 
While this thesis has not shown a causal link between these aspects and the metrics, it has 
shown they are related. EDP was known for the previous models, but the average EDP of the 
previous cohort was assumed for the new patients. It is possible that not having this 
information is partially responsible for the relatively homogeneous models. The disadvantage 
of cardiac catheterization to get the pressure tracings is that it is an invasive procedure. There 
exist echocardiographic methods for estimating EDP, which could help make the metrics 
more representative of the patients, however these methods are better for estimating pressure 
gradients than absolute values [43] [44] [45] [46]. Also, ventricular filling via pulmonary 
pressures and atrial mechanics were found to be important. Pulmonary pressures can be 
estimated echocardiographically, though the accuracy of this method is debatable [47]. These 
somewhat inaccurate estimates may be better than not including this information at all as in 
the new models. Similarly, atrial mechanics can be estimated echocardiographically, but there 
are not clear standards or rigorous validation [48]. Because other pressure information like the 
dP/dt max and dP/dt min were not found to be important, a left heart catheterization may not 
be necessary. A right heart catheterization, which is much more routine but still invasive, may 
be able to provide enough information to make accurate models. The specificity of the metrics 
to EDP and ventricular filling mechanics in general should be studied first to determine 
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whether the invasive pressure tracing, invasive but routine EDP measurement, or the 
somewhat inaccurate echocardiographic estimates should be used in future models. 
   
4.2  Limitations 
The patient-specific geometries were segmented automatically using a threshold and 
the parts that are not needed are trimmed away manually. This is subject to user error, because 
sometimes the distinction between cardiac tissue and other surrounding tissues, such as 
hepatic tissue or the bone and muscle of the ribcage, is not clear. The choice of the valve 
plane is subjective, because the valves do not actually lie on the same plane. This could cause 
differences in the volume of the heart and shape of the heart near the base. A balance between 
fitting the data and good mesh quality also means that the patient-specific models can vary a 
little from the actual CT data. Finally, the highly detailed CT data is down sampled to just 209 
nodes, and the elements are interpolated according to a prolate spheroidal assumption. This 
means that the geometries are approximations to the patient geometries rather than precise 
reconstructions of the geometries. 
Many circulation model parameters are unknowns and are found by physiological 
rules in the CircAdapt program. The model is most sensitive to these parameters, so it is 
important that these parameters make sense with the patients’ observed physiology. 
These models take a very long time to develop. It took one year to develop these five, 
though the techniques are improving constantly. If these models are to be run to provide 
clinicians with information before patients are implanted, the workflow will need a major 
improvement and the computational runtime, currently 6 days for just the final simulation, 
will need to be much faster. 
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4.3  Future Studies 
Though the patient groups in this thesis are not identical, the metrics used to evaluate 
dyssynchrony were not similar in the two groups. Perhaps the previous models should be 
created again in a blinded fashion using the same methods as the new models, and the metrics 
can be compared to see what effect knowing the invasive measurements had. 
More needs to be known about the sensitivity of these models to the particular 
parameters that go into them. The circulation model, especially the EDP and ventricular 
filling mechanics should have its own sensitivity analysis performed. Then, whether the 
echocardiographic estimates or invasive but routine measurements of some of these 
parameters is good enough to provide reasonable accuracy for work metrics can be 
determined.   
Because many patients do not receive cardiac CT, it can be difficult to build the 
patient-specific cardiac geometries. Because the average geometry did not worsen the 
correlation between metrics and ESV reduction, it may be possible to use an average 
geometry or scale an average geometry to fit the echocardiographic measurements of a 
patient. This may increase model throughput as well, because manual CT segmentation could 
be avoided. 
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